BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Hitachi's Proton Therapy System Now in Use at National Cancer Centre Singapore

This system, installed in the basement of the new building of NCCS with 24 floors above ground, consists of five treatment rooms, four with rotating gantri...

October 05, 2023 | News

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

October 03, 2023 | News

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

Established in 1970, SRL Inc (a subsidiary of H.U Group Holdings Inc.), is a renowned clinical laboratory testing company in Japan with over 80 n...

October 03, 2023 | News

Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors

An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...

September 29, 2023 | News

Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women English

Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launched the "Bayer for Her" campaign, underscoring the i...

September 27, 2023 | News

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, announced ...

September 26, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

September 26, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

September 25, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

SMi Systems has secured a patent from the UK Intellectual Property Office (IPO) for the single-molecule imaging technologies that underpin its super-resolu...

September 18, 2023 | News

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...

September 15, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...

September 12, 2023 | News

Genesis MedTech Unveils China's First NPMA-Approved Antibacterial Sutures

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and...

September 12, 2023 | News

Stay Connected